Peoples Financial Services Corp’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$149K Hold
2,692
0.07% 149
2025
Q4
$132K Hold
2,692
0.06% 152
2025
Q3
$116K Hold
2,692
0.05% 155
2025
Q2
$103K Hold
2,692
0.05% 154
2025
Q1
$104K Sell
2,692
-160
-6% -$5.86K 0.05% 154
2024
Q4
$96.4K Hold
2,852
0.04% 149
2024
Q3
$117K Hold
2,852
0.05% 142
2024
Q2
$110K Hold
2,852
0.05% 142
2024
Q1
$122K Hold
2,852
0.05% 140
2023
Q4
$106K Hold
2,852
0.05% 145
2023
Q3
$103K Sell
2,852
-320
-10% -$11.4K 0.05% 148
2023
Q2
$113K Sell
3,172
-1,400
-31% -$50.2K 0.05% 147
2023
Q1
$163K Sell
4,572
-600
-12% -$21K 0.08% 139
2022
Q4
$182K Sell
5,172
-400
-7% -$13.3K 0.09% 139
2022
Q3
$164K Sell
5,572
-605
-10% -$22.9K 0.08% 137
2022
Q2
$336K Hold
6,177
0.16% 114
2022
Q1
$336K Sell
6,177
-800
-11% -$43.5K 0.15% 123
2021
Q4
$384K Sell
6,977
-320
-4% -$16.6K 0.15% 114
2021
Q3
$349K Sell
7,297
-480
-6% -$24.1K 0.15% 118
2021
Q2
$387K Sell
7,777
-960
-11% -$46.1K 0.16% 106
2021
Q1
$390K Sell
8,737
-880
-9% -$39.9K 0.17% 100
2020
Q4
$443K Hold
9,617
0.2% 90
2020
Q3
$453K Hold
9,617
0.23% 85
2020
Q2
$490K Buy
9,617
+45
+0.5% +$2.31K 0.26% 79
2020
Q1
$453K Hold
9,572
0.27% 80
2019
Q4
$562K Sell
9,572
-160
-2% -$8.9K 0.27% 84
2019
Q3
$519K Sell
9,732
-110
-1% -$5.66K 0.26% 82
2019
Q2
$492K Hold
9,842
0.25% 83
2019
Q1
$514K Hold
9,842
0.26% 81
2018
Q4
$470K Sell
9,842
-848
-8% -$41.8K 0.27% 82
2018
Q3
$536K Hold
10,690
0.27% 79
2018
Q2
$539K Sell
10,690
-120
-1% -$6.04K 0.3% 79
2018
Q1
$527K Sell
10,810
-400
-4% -$18.6K 0.3% 81
2017
Q4
$497K Sell
11,210
-1,760
-14% -$81.3K 0.27% 82
2017
Q3
$658K Sell
12,970
-240
-2% -$12.2K 0.37% 70
2017
Q2
$712K Sell
13,210
-240
-2% -$12.8K 0.42% 70
2017
Q1
$709K Sell
13,450
-3,730
-22% -$189K 0.42% 68
2016
Q4
$931K Sell
17,180
-30
-0.2% -$1.48K 0.57% 54
2016
Q3
$928K Buy
17,210
+30
+0.2% +$1.65K 0.58% 54
2016
Q2
$931K Sell
17,180
-80
-0.5% -$4.21K 0.57% 54
2016
Q1
$875K Buy
17,260
+4,360
+34% +$217K 0.55% 52
2015
Q4
$650K Sell
12,900
-400
-3% -$20.4K 0.43% 65
2015
Q3
$639K Sell
13,300
-40
-0.3% -$2.08K 0.46% 66
2015
Q2
$694K Buy
13,340
+360
+3% +$20.3K 0.46% 65
2015
Q1
$748K Sell
12,980
-8
-0.1% -$459 0.49% 59
2014
Q4
$694K Buy
12,988
+240
+2% +$13.4K 0.45% 64
2014
Q3
$732K Buy
12,748
+3,160
+33% +$194K 0.49% 58
2014
Q2
$641K Sell
9,588
-440
-4% -$29.8K 0.41% 68
2014
Q1
$670K Sell
10,028
-180
-2% -$12.2K 0.5% 61
2013
Q4
$682K Buy
+10,208
New +$662K 0.45% 61

Other funds holding GSK

Peoples Financial Services Corp's GSK Position: Q1 2026 in Review

Peoples Financial Services Corp held its GSK (GSK) position steady in Q1 2026 at 2,692 shares worth $149K. The position accounts for 0.07% of the portfolio, ranked #149.

Peoples Financial Services Corp first reported a position in GSK in Q4 2013 and has held it in 50 quarters since. The position peaked at $931K in Q4 2016. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Peoples Financial Services Corp held 2,692 shares of GSK worth $149K as of Q1 2026.
  • Peoples Financial Services Corp left its GSK share count unchanged in Q1 2026.
  • GSK made up 0.07% of Peoples Financial Services Corp's portfolio in Q1 2026, its #149 holding.
  • Peoples Financial Services Corp first reported a position in GSK in Q4 2013 and has held it in 50 quarters since.
  • Peoples Financial Services Corp's GSK position peaked at $931K in Q4 2016.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Peoples Financial Services Corp's 13F filing for Q1 2026, filed 20 Apr 2026.